Ani Pharmaceuticals Inc. (ANIP)
NASDAQ · Healthcare
Ani Pharmaceuticals Inc. EBITDA 2009–2025
Ani Pharmaceuticals Inc. annual/quarterly ebitda history and growth rate from 2012 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Ani Pharmaceuticals Inc. ebitda for the quarter ending March 31, 2026 was 59.8 M, a 21.84% increase year-over-year.
- Ani Pharmaceuticals Inc. ebitda for the twelve months ending March 31, 2026 was 204.9 M, a 146.18% increase year-over-year.
- Ani Pharmaceuticals Inc. annual ebitda for 2025 was 202.5 M, a 196.44% increase from 2024.
- Ani Pharmaceuticals Inc. annual ebitda for 2024 was 68.3 M, a 36.01% decrease from 2023.
- Ani Pharmaceuticals Inc. annual ebitda for 2023 was 106.8 M, a 392.24% increase from 2022.
- Ani Pharmaceuticals Inc. annual ebitda for 2022 was 21.7 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ani Pharmaceuticals Inc. EBITDA — FAQ
Ani Pharmaceuticals Inc. (ANIP) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANIP's ebitda history?
The chart and table above show Ani Pharmaceuticals Inc.'s ebitda by year and by quarter, including the growth rate.